Summary. Chemical sympathectomy followed transluminal perfusion of the rabbit oviduct with 6-hydroxydopamine (6-OHDA). Histofluorescence studies 1 week after perfusion revealed an absence of formaldehyde-norepinephrine(NE)-induced fluorescence in treated oviducts while contralateral control oviducts which were not perfused exhibited normal fluorescence. Endogenous NE concentrations of treated and control oviducts and their associated uterine horns were measured biochemically 1 week after perfusion. A dose-dependent decrease in NE was demonstrated in 6-OHDA-perfused oviducts. By contrast, contralateral control oviducts and both uterine horns exhibited no significant decrease in endogenous NE until doses of 6-OHDA in excess of those required for functional denervation were perfused through treated oviducts.
INTRODUCTION
The incomplete understanding of the rôle of the sympathetic nervous system in the physiology of the mammalian oviduct is due largely to the lack of an effec¬ tive technique for achieving an efficient, controlled sympathectomy. The use of norepinephrine(NE)-depleting drugs to produce a pharmacological denervation of the oviduct also causes alteration of function in organs unrelated to the oviduct. Similarly, the use of receptor blockers to achieve functional denerva¬ tion suffers the same shortcoming.
Attempts to achieve a specific denervation of the oviducts have generally involved a surgical approach. Surgical sympathectomy of the oviduct, however, requires extensive transection and probably leads to parasympathectomy as well.
In addition, anatomical variation between animals leads to inconsistent results.
Recent studies have shown that 6-hydroxydopamine (6-OHDA) is capable of inducing selective degeneration of terminal adrenergic nerve endings without affecting cholinergic nerve terminals  Knyihar, Ristovsky, Kaiman & Csillik, 1969;  Bennett, Burnstock, Cobb & Malmfors, 1970; de Champlain & Nadeau, 1971) . Depletion of endogenous NE is rapid and complete when sufficient quantities of 6-OHDA are administered. Systemically administered 6-OHDA is taken up by the adrenergic nerve endings of virtually every tissue resulting in a drug-induced sympathectomy (Malmfors & Sachs, 1968 Following perfusion, the laparatomy incisions were sutured and the animals were returned to individual cages. Endogenous NE levels of treated and contralateral control oviducts were determined biochemically (Maickel, Cox, Saillant & Miller, 1968) and histofluorometrically (Falck & Owman, 1965) (1968) , with the following modi¬ fications: (1) the amount of OT N-HC1 used for aqueous extraction of NE was doubled (to 0-8 ml) ; (2) the aliquot of OT n-HCI aqueous phase used for oxida¬ tion to NE photofluor was 0-5 ml (instead of OT ml); (3) the recovery of NE was monitored, using [3H]NE added to the tissues after homogenization.
Average recovery of NE for the complete procedure was 97% for standards and 74% for tissue. Oviduct NE values were uncorrected for non-specific tissue fluorescence. Pretreatment with 10 mg Reserpine 36 hr and 18 hr before assay was found to give readings which were 11 to 13 % those of control read¬ ings. Levels of NE were computed both for individual segments and for whole oviducts and were expressed as /¿g NE/g tissue. In the latter case, the NE con¬ centration was computed as the average of the concentrations of the five segments composing the oviduct.
Histofluorescence
Sections of trimmed oviduct were prepared for fluorescence microscopy according to the technique of Falck & Hillarp (Falck & Owman, 1965) . Tissues were quickly frozen in liquid nitrogen-cooled isopentane and transferred to a Virtis freeze dryer. Following a 3-to 5-day period of desiccation under vacuum at -35°C , the dehydrated tissue was exposed to paraformaldehyde vapour at optimum humidity for 1 hr at 80°C. The tissue was then vacuumembedded in paraffin wax and 9-µ sections were cut and mounted in Entellan for fluorescence microscopy.
Histology
In order to rule out perfusion-and drug-induced trauma, random portions of treated and control oviducts were fixed in Bouin's fluid and embedded in paraffin wax. Sections of 5 to 7 µ were stained with haematoxylin and eosin and viewed under light microscopy (Guyer, 1953) . The statistical significance between control and 6-OHDA-treated oviducts was calculated by analysis of variance and Duncan's New Multiple Range Test (Steel & Torrie, 1960) . 
RESULTS

Biochemical assay
The NE content of rabbit oviducts was measured within 1 week after trans¬ luminal perfusion with 6-OHDA. Reduction of NE in treated oviducts was observed throughout the dose range used ( Table 2 ). The effect of 6-OHDA, In animals treated with 0-5 mg 6-OHDA/oviduct, control oviducts showed a rather large average reduction in NE content of 37%. By contrast, increases of 35 and 26% above control group values were seen in the 1 -0 and 5-0 mg/oviduct groups, respectively. Depletion in NE, however, was again seen in the 10-0 and 20-0 mg/oviduct groups as increasing systemic effects produced a 28 and 56% reduction in NE content, respectively (Text- fig. 2 ).
The NE-depleting effect of 6-OHDA upon various segments of the oviduct, expressed as the percentage change from the appropriate control group segment, is shown in Table 4 . (Table 4 ). The response pattern of both uterine horns was found to be qualitatively similar to PLATE 1 Fig. 1 . Cross-section of a control (not perfused) rabbit oviduct from the area of the ampullary-isthmic junction (Segment 3). The contralateral oviduct was perfused with 5-0 mg 6-OHDA. 185. Fig. 2 . Gross-section of a rabbit oviduct perfused with 5-0 mg 6-OHDA. The contralateral control oviduct appears in Fig. 1. 189. (Facing p. 6) 7 that of oviduct tissue which had not been perfused. Levels of NE were not significantly affected in either group throughout the dose range of 6-OHDA used.
Histofluorescence Histofluorescent observation of the adrenergic innervation of control and perfused oviducts generally correlated with the results obtained from the bio¬ chemical assay. The lowest dose of 6-OHDA (0-5 mg/oviduct) produced a moderate decrease in fluorescence in both perfused and control oviducts which was quantitatively indistinguishable. Normal, profuse, well-defined fluorescence was seen in control oviducts of the 1-0 and 5-0 mg/oviduct groups (PL 1, Fig. 1 ). By contrast, oviducts perfused with 1-0 mg 6-OHDA exhibited sparse, weak fluorescence and those perfused with 5-0 mg 6-OHDA were essentially devoid of fluorescence (PL 1, Fig. 2 ). Control oviducts of the 10-0 mg/oviduct group exhibited extensive fluorescence, though this lacked the usual crispness seen in oviducts of the control group. Fluorescence was absent from corresponding perfused oviducts. Perfusion with 20-0 mg 6-OHDA severely depleted fluores¬ cence in control oviducts and led to its absence in treated oviducts.
Histology
Histological findings revealed no disruptive effect, either mechanical or chemical, resulting from the perfusion procedure.
DISCUSSION
It has been shown that 6-OHDA produces a marked and prolonged depletion of NE after systemic administration  Mueller, Thoenen & Axelrod, 1969; Goldman & Jacobowitz, 1971; de Champlain & Nadeau, 1971) . In the present study, a similar depletion obtained by perfusing 6-OHDA through the tubai lumen of the oviduct has been demonstrated. Unlike systemically administered 6-OHDA which produces widespread depletion of NE, transluminally perfused 6-OHDA, particularly within the 1 ¬ 5-0-mg/oviduct dose range, depletes only the perfused oviduct. As the dose of 6-OHDA perfused through the treated oviduct was increased beyond approxi¬ mately 7 0 mg/oviduct, a dose-dependent decrease in the NE content of the control oviducts was established. This was consistent with an increased entry of 6-OHDA into the general circulation and, hence, of a greater uptake by tissue which was not perfused. It is of interest to note that the response pattern of uterine tissue was qualitatively similar to that of the oviducts which were not perfused (Table 4) .
The observation that 0-5 mg/oviduct of 6-OHDA caused a 37% decrease in NE levels in control oviducts is difficult to resolve with the theory of increasing systemic effect as the dose of 6-OHDA is increased. Unpublished data (T. D. Traylor in Bréese & Traylor, 1970) The demonstration of a graded depletion of NE in response to given levels of 6-OHDA exhibited by various segments of the rabbit oviduct may be due to differences in sensitivity of those segments to the NE-depleting effect of the drug. Differences in the sensitivity of various organs to the effect of 6-OHDA has been noted (Malmfors & Sachs, 1968 ; . The iris has been found to be a very sensitive organ, while the vas deferens and adrenergic ganglia are largely unaffected by 6-OHDA. Such differences may be due to the different types of post-ganglionic neurones innervating these organs, or to differences in blood perfusion or local tissue 6-OHDA uptake and concentration. It has been shown that, in order to exert its effect, 6-OHDA must be taken up by the adrenergic nerve ending (Malmfors & Sachs, 1968 (Goldman & Jacobowitz, 1971) , despite severely depleted tissue NE stores, makes it likely that much of the remaining 30% NE is vascular and not asso¬ ciated with the smooth musculature of the oviduct.
